Navigation Links
CSC's Dr. Robert M. Wah Makes Top 10 in 50 Most Powerful Physician Executives List
Date:4/30/2008

FALLS CHURCH, Va., April 30 /PRNewswire/ -- Computer Sciences Corporation (NYSE: CSC) today announced that Dr. Robert M. Wah, chief medical officer and vice president of its North American Public Sector business unit, has been ranked number 10 in Modern Physician and Modern Healthcare magazines' annual ranking of the 50 Most Powerful Physician Executives, published in April. Readers from both magazines nominated 7,300 physician executives for the fourth annual ranking. Of the top 100 most-nominated candidates, nearly 20,000 ballots were cast to determine the top 50. This year, Dr. Wah advanced four places in his ranking from number 14 in last year's poll.

"This ranking reflects Dr. Wah's commitment and leadership to transform healthcare with better information for better decisions," said Raymond E. Henry, president of CSC's North American Public Sector Government Health Services division. "We congratulate Dr. Wah on this recognition of his many accomplishments. He is an expert in health information systems and his successes show our customers that they can count on us to improve the quality of patient care through the use of information technology."

Dr. Wah's focus is on managing and growing business with federal and state government agencies responsible for healthcare, and working closely with CSC's commercial and international business units that serve the healthcare sector.

Since joining CSC in 2007, Dr. Wah has applied his insights and expertise to many of the company's client programs, including occupational healthcare in high-risk locations such as the Hanford Nuclear facility; claims processing for eMedNY, the New York Medicaid system which handled 600 million transactions last year with no downtime; and bringing new discoveries from the lab to patients at DynPort Vaccine Company LLC. He is also working on bioinformatics harnessing technology to extract value from data and connecting data islands around the globe with CSC projects such as the Nationwide Health Information Network trial implementation in the United States, and projects in the United Kingdom, the Netherlands and Denmark.

Dr. Wah continues to be an active leader within the overall healthcare industry, serving on multiple boards and teaching at educational institutions. He is also often sought by the media for his expertise and regularly speaks at industry conferences.

Prior to joining CSC, Dr. Wah served as acting deputy national coordinator for health information technology (IT) at the U.S. Department of Health and Human Services. He also worked for the Military Health System in the Office of the Secretary of Defense as the associate chief information officer and director of information management. In addition, he served 23 years in the Navy Medical Corps, most recently at the rank of captain.

About CSC

Computer Sciences Corporation is a leading global IT services company. CSC's mission is to provide customers in industry and government with solutions crafted to meet their specific challenges and enable them to profit from the advanced use of technology.

With approximately 91,000 employees, CSC provides innovative solutions for customers around the world by applying leading technologies and CSC's own advanced capabilities. These include systems design and integration; IT and business process outsourcing; applications software development; Web and application hosting; and management consulting. CSC reported revenue of $16.1 billion for the 12 months ended Dec. 28, 2007. For more information, visit the company's Web site at http://www.csc.com.


'/>"/>
SOURCE Computer Sciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development
2. Wyeth Chairman Robert Essner Announces June 27 Retirement
3. Genetic Engineering and Biotechnology News (GEN) Presents Exclusive Podcast with Robert Langer, Ph.D. on New Polymeric Drug Delivery Systems
4. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
5. Hiemstra Appoints Robert C. Glines as Director of Business Development
6. WellGen, Inc. Names Robert M. Hellauer as Chief Financial Officer
7. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
8. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
9. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
10. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
11. Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):